Table 2.

Drinking risk level at baseline and month 13 from the 1-year double-blind randomized controlled trials.

Time point	Women (n = 42)		Men (n = 141)
Drinking level	Placebo	Nalmefene	Placebo	Nalmefene
Baseline
High	4	10	19	63
Very high	6	22	13	46
Month 13a
Abstinence or low	3	19	13	63
Medium or above	7	13	19	46

^a13 months of 28 days.

Note: Drinking risk level (DRL, low, medium, high, very high) as defined in the Methods section. Missing values were handled using the last observation carried forward.